Studies on drug resistance. V. Combination chemotherapy with cytosine arabinoside (NSC-63878) plus 6-thioguanine (NSC-752) in cytosine arabinoside-sensitive and -resistant P815 mouse neoplasms.
D000818:Animals; D003561:Cytarabine / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D013866:Thioguanine / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D003561:Cytarabine; D013866:Thioguanine